Prostate Cancer Chemotherapy Drugs Market, Global Outlook and Forecast 2022-2028
The most common chemotherapy drug for prostate cancer is docetaxel (Taxotere), which is usually given with prednisone, a steroid medicine. After starting docetaxel, many men experience the improvements in disease-related symptoms, including pain, fatigue and loss of energy.
This report contains market size and forecasts of Prostate Cancer Chemotherapy Drugs in global, including the following market information:
Global Prostate Cancer Chemotherapy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prostate Cancer Chemotherapy Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Prostate Cancer Chemotherapy Drugs companies in 2021 (%)
The global Prostate Cancer Chemotherapy Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Abiraterone Acetate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Chemotherapy Drugs include Johnson & Johnson, Pfizer, Roche, Novartis, AbbVie, Bristol-Myer, Sanofi, AstraZeneca and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Cancer Chemotherapy Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Chemotherapy Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prostate Cancer Chemotherapy Drugs Market Segment Percentages, by Type, 2021 (%)
Global Prostate Cancer Chemotherapy Drugs Market Segment Percentages, by Application, 2021 (%)
Global Prostate Cancer Chemotherapy Drugs Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Chemotherapy Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prostate Cancer Chemotherapy Drugs revenues share in global market, 2021 (%)
Key companies Prostate Cancer Chemotherapy Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Prostate Cancer Chemotherapy Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Prostate Cancer Chemotherapy Drugs in global, including the following market information:
Global Prostate Cancer Chemotherapy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prostate Cancer Chemotherapy Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Prostate Cancer Chemotherapy Drugs companies in 2021 (%)
The global Prostate Cancer Chemotherapy Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Abiraterone Acetate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Chemotherapy Drugs include Johnson & Johnson, Pfizer, Roche, Novartis, AbbVie, Bristol-Myer, Sanofi, AstraZeneca and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Cancer Chemotherapy Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Chemotherapy Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prostate Cancer Chemotherapy Drugs Market Segment Percentages, by Type, 2021 (%)
- Abiraterone Acetate
- Apalutamide
- Bicalutamide
- Cabazitaxel
- Others
Global Prostate Cancer Chemotherapy Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Other
Global Prostate Cancer Chemotherapy Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Chemotherapy Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prostate Cancer Chemotherapy Drugs revenues share in global market, 2021 (%)
Key companies Prostate Cancer Chemotherapy Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Prostate Cancer Chemotherapy Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson & Johnson
- Pfizer
- Roche
- Novartis
- AbbVie
- Bristol-Myer
- Sanofi
- AstraZeneca
- Merck
- Amgen
- Bayer AG
- Ipsen Group
- Endo Pharmaceuticals
- Dendreon Corporation
- Myovant Biosciences
- Effector Therapeutics
- Mediolanum
- ESSA Pharma
- Astellas Pharma
- Janssen
- Eli Lilly and Company
- POINT Biopharma
- Hinnova Pharmaceuticals
- Sophiris Bio
- Ultimovacs
- Foresee Pharmaceuticals
- Luye Pharma Group
- Abbott
- Jiangsu HengRui Medicine
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Prostate Cancer Chemotherapy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Chemotherapy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PROSTATE CANCER CHEMOTHERAPY DRUGS OVERALL MARKET SIZE
2.1 Global Prostate Cancer Chemotherapy Drugs Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Chemotherapy Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Prostate Cancer Chemotherapy Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Prostate Cancer Chemotherapy Drugs Players in Global Market
3.2 Top Global Prostate Cancer Chemotherapy Drugs Companies Ranked by Revenue
3.3 Global Prostate Cancer Chemotherapy Drugs Revenue by Companies
3.4 Global Prostate Cancer Chemotherapy Drugs Sales by Companies
3.5 Global Prostate Cancer Chemotherapy Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Prostate Cancer Chemotherapy Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Prostate Cancer Chemotherapy Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prostate Cancer Chemotherapy Drugs Players in Global Market
3.8.1 List of Global Tier 1 Prostate Cancer Chemotherapy Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Prostate Cancer Chemotherapy Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Chemotherapy Drugs Market Size Markets, 2021 & 2028
4.1.2 Abiraterone Acetate
4.1.3 Apalutamide
4.1.4 Bicalutamide
4.1.5 Cabazitaxel
4.1.6 Others
4.2 By Type - Global Prostate Cancer Chemotherapy Drugs Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Chemotherapy Drugs Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Chemotherapy Drugs Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Prostate Cancer Chemotherapy Drugs Sales & Forecasts
4.3.1 By Type - Global Prostate Cancer Chemotherapy Drugs Sales, 2017-2022
4.3.2 By Type - Global Prostate Cancer Chemotherapy Drugs Sales, 2023-2028
4.3.3 By Type - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Prostate Cancer Chemotherapy Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Chemotherapy Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Sales
5.1.5 Other
5.2 By Application - Global Prostate Cancer Chemotherapy Drugs Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Chemotherapy Drugs Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Chemotherapy Drugs Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Prostate Cancer Chemotherapy Drugs Sales & Forecasts
5.3.1 By Application - Global Prostate Cancer Chemotherapy Drugs Sales, 2017-2022
5.3.2 By Application - Global Prostate Cancer Chemotherapy Drugs Sales, 2023-2028
5.3.3 By Application - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Prostate Cancer Chemotherapy Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Prostate Cancer Chemotherapy Drugs Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Chemotherapy Drugs Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Chemotherapy Drugs Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Chemotherapy Drugs Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Prostate Cancer Chemotherapy Drugs Sales & Forecasts
6.3.1 By Region - Global Prostate Cancer Chemotherapy Drugs Sales, 2017-2022
6.3.2 By Region - Global Prostate Cancer Chemotherapy Drugs Sales, 2023-2028
6.3.3 By Region - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028
6.4.2 By Country - North America Prostate Cancer Chemotherapy Drugs Sales, 2017-2028
6.4.3 US Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.4.4 Canada Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.4.5 Mexico Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Prostate Cancer Chemotherapy Drugs Sales, 2017-2028
6.5.3 Germany Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.4 France Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.5 U.K. Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.6 Italy Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.7 Russia Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.9 Benelux Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Prostate Cancer Chemotherapy Drugs Sales, 2017-2028
6.6.3 China Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.6.4 Japan Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.6.5 South Korea Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.6.7 India Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028
6.7.2 By Country - South America Prostate Cancer Chemotherapy Drugs Sales, 2017-2028
6.7.3 Brazil Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.7.4 Argentina Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales, 2017-2028
6.8.3 Turkey Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.8.4 Israel Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.8.6 UAE Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.1.4 Johnson & Johnson Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.2.4 Pfizer Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.3.4 Roche Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.4.4 Novartis Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Novartis Key News
7.5 AbbVie
7.5.1 AbbVie Corporate Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.5.4 AbbVie Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.5.5 AbbVie Key News
7.6 Bristol-Myer
7.6.1 Bristol-Myer Corporate Summary
7.6.2 Bristol-Myer Business Overview
7.6.3 Bristol-Myer Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.6.4 Bristol-Myer Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Bristol-Myer Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.7.4 Sanofi Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Sanofi Key News
7.8 AstraZeneca
7.8.1 AstraZeneca Corporate Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.8.4 AstraZeneca Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.8.5 AstraZeneca Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.9.4 Merck Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Merck Key News
7.10 Amgen
7.10.1 Amgen Corporate Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.10.4 Amgen Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Amgen Key News
7.11 Bayer AG
7.11.1 Bayer AG Corporate Summary
7.11.2 Bayer AG Prostate Cancer Chemotherapy Drugs Business Overview
7.11.3 Bayer AG Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.11.4 Bayer AG Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Bayer AG Key News
7.12 Ipsen Group
7.12.1 Ipsen Group Corporate Summary
7.12.2 Ipsen Group Prostate Cancer Chemotherapy Drugs Business Overview
7.12.3 Ipsen Group Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.12.4 Ipsen Group Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Ipsen Group Key News
7.13 Endo Pharmaceuticals
7.13.1 Endo Pharmaceuticals Corporate Summary
7.13.2 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Business Overview
7.13.3 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.13.4 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Endo Pharmaceuticals Key News
7.14 Dendreon Corporation
7.14.1 Dendreon Corporation Corporate Summary
7.14.2 Dendreon Corporation Business Overview
7.14.3 Dendreon Corporation Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.14.4 Dendreon Corporation Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Dendreon Corporation Key News
7.15 Myovant Biosciences
7.15.1 Myovant Biosciences Corporate Summary
7.15.2 Myovant Biosciences Business Overview
7.15.3 Myovant Biosciences Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.15.4 Myovant Biosciences Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Myovant Biosciences Key News
7.16 Effector Therapeutics
7.16.1 Effector Therapeutics Corporate Summary
7.16.2 Effector Therapeutics Business Overview
7.16.3 Effector Therapeutics Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.16.4 Effector Therapeutics Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Effector Therapeutics Key News
7.17 Mediolanum
7.17.1 Mediolanum Corporate Summary
7.17.2 Mediolanum Business Overview
7.17.3 Mediolanum Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.17.4 Mediolanum Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.17.5 Mediolanum Key News
7.18 ESSA Pharma
7.18.1 ESSA Pharma Corporate Summary
7.18.2 ESSA Pharma Business Overview
7.18.3 ESSA Pharma Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.18.4 ESSA Pharma Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.18.5 ESSA Pharma Key News
7.19 Astellas Pharma
7.19.1 Astellas Pharma Corporate Summary
7.19.2 Astellas Pharma Business Overview
7.19.3 Astellas Pharma Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.19.4 Astellas Pharma Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.19.5 Astellas Pharma Key News
7.20 Janssen
7.20.1 Janssen Corporate Summary
7.20.2 Janssen Business Overview
7.20.3 Janssen Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.20.4 Janssen Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.20.5 Janssen Key News
7.21 Eli Lilly and Company
7.21.1 Eli Lilly and Company Corporate Summary
7.21.2 Eli Lilly and Company Business Overview
7.21.3 Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.21.4 Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.21.5 Eli Lilly and Company Key News
7.22 POINT Biopharma
7.22.1 POINT Biopharma Corporate Summary
7.22.2 POINT Biopharma Business Overview
7.22.3 POINT Biopharma Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.22.4 POINT Biopharma Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.22.5 POINT Biopharma Key News
7.23 Hinnova Pharmaceuticals
7.23.1 Hinnova Pharmaceuticals Corporate Summary
7.23.2 Hinnova Pharmaceuticals Business Overview
7.23.3 Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.23.4 Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.23.5 Hinnova Pharmaceuticals Key News
7.24 Sophiris Bio
7.24.1 Sophiris Bio Corporate Summary
7.24.2 Sophiris Bio Business Overview
7.24.3 Sophiris Bio Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.24.4 Sophiris Bio Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.24.5 Sophiris Bio Key News
7.25 Ultimovacs
7.25.1 Ultimovacs Corporate Summary
7.25.2 Ultimovacs Business Overview
7.25.3 Ultimovacs Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.25.4 Ultimovacs Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.25.5 Ultimovacs Key News
7.26 Foresee Pharmaceuticals
7.26.1 Foresee Pharmaceuticals Corporate Summary
7.26.2 Foresee Pharmaceuticals Business Overview
7.26.3 Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.26.4 Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.26.5 Foresee Pharmaceuticals Key News
7.27 Luye Pharma Group
7.27.1 Luye Pharma Group Corporate Summary
7.27.2 Luye Pharma Group Business Overview
7.27.3 Luye Pharma Group Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.27.4 Luye Pharma Group Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.27.5 Luye Pharma Group Key News
7.28 Abbott
7.28.1 Abbott Corporate Summary
7.28.2 Abbott Business Overview
7.28.3 Abbott Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.28.4 Abbott Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.28.5 Abbott Key News
7.29 Jiangsu HengRui Medicine
7.29.1 Jiangsu HengRui Medicine Corporate Summary
7.29.2 Jiangsu HengRui Medicine Business Overview
7.29.3 Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.29.4 Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.29.5 Jiangsu HengRui Medicine Key News
8 GLOBAL PROSTATE CANCER CHEMOTHERAPY DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Prostate Cancer Chemotherapy Drugs Production Capacity, 2017-2028
8.2 Prostate Cancer Chemotherapy Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Prostate Cancer Chemotherapy Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PROSTATE CANCER CHEMOTHERAPY DRUGS SUPPLY CHAIN ANALYSIS
10.1 Prostate Cancer Chemotherapy Drugs Industry Value Chain
10.2 Prostate Cancer Chemotherapy Drugs Upstream Market
10.3 Prostate Cancer Chemotherapy Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prostate Cancer Chemotherapy Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Prostate Cancer Chemotherapy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Chemotherapy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PROSTATE CANCER CHEMOTHERAPY DRUGS OVERALL MARKET SIZE
2.1 Global Prostate Cancer Chemotherapy Drugs Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Chemotherapy Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Prostate Cancer Chemotherapy Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Prostate Cancer Chemotherapy Drugs Players in Global Market
3.2 Top Global Prostate Cancer Chemotherapy Drugs Companies Ranked by Revenue
3.3 Global Prostate Cancer Chemotherapy Drugs Revenue by Companies
3.4 Global Prostate Cancer Chemotherapy Drugs Sales by Companies
3.5 Global Prostate Cancer Chemotherapy Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Prostate Cancer Chemotherapy Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Prostate Cancer Chemotherapy Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prostate Cancer Chemotherapy Drugs Players in Global Market
3.8.1 List of Global Tier 1 Prostate Cancer Chemotherapy Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Prostate Cancer Chemotherapy Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Chemotherapy Drugs Market Size Markets, 2021 & 2028
4.1.2 Abiraterone Acetate
4.1.3 Apalutamide
4.1.4 Bicalutamide
4.1.5 Cabazitaxel
4.1.6 Others
4.2 By Type - Global Prostate Cancer Chemotherapy Drugs Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Chemotherapy Drugs Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Chemotherapy Drugs Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Prostate Cancer Chemotherapy Drugs Sales & Forecasts
4.3.1 By Type - Global Prostate Cancer Chemotherapy Drugs Sales, 2017-2022
4.3.2 By Type - Global Prostate Cancer Chemotherapy Drugs Sales, 2023-2028
4.3.3 By Type - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Prostate Cancer Chemotherapy Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Chemotherapy Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Sales
5.1.5 Other
5.2 By Application - Global Prostate Cancer Chemotherapy Drugs Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Chemotherapy Drugs Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Chemotherapy Drugs Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Prostate Cancer Chemotherapy Drugs Sales & Forecasts
5.3.1 By Application - Global Prostate Cancer Chemotherapy Drugs Sales, 2017-2022
5.3.2 By Application - Global Prostate Cancer Chemotherapy Drugs Sales, 2023-2028
5.3.3 By Application - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Prostate Cancer Chemotherapy Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Prostate Cancer Chemotherapy Drugs Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Chemotherapy Drugs Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Chemotherapy Drugs Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Chemotherapy Drugs Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Prostate Cancer Chemotherapy Drugs Sales & Forecasts
6.3.1 By Region - Global Prostate Cancer Chemotherapy Drugs Sales, 2017-2022
6.3.2 By Region - Global Prostate Cancer Chemotherapy Drugs Sales, 2023-2028
6.3.3 By Region - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028
6.4.2 By Country - North America Prostate Cancer Chemotherapy Drugs Sales, 2017-2028
6.4.3 US Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.4.4 Canada Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.4.5 Mexico Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Prostate Cancer Chemotherapy Drugs Sales, 2017-2028
6.5.3 Germany Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.4 France Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.5 U.K. Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.6 Italy Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.7 Russia Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.5.9 Benelux Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Prostate Cancer Chemotherapy Drugs Sales, 2017-2028
6.6.3 China Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.6.4 Japan Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.6.5 South Korea Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.6.7 India Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028
6.7.2 By Country - South America Prostate Cancer Chemotherapy Drugs Sales, 2017-2028
6.7.3 Brazil Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.7.4 Argentina Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales, 2017-2028
6.8.3 Turkey Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.8.4 Israel Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
6.8.6 UAE Prostate Cancer Chemotherapy Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.1.4 Johnson & Johnson Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.2.4 Pfizer Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.3.4 Roche Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.4.4 Novartis Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Novartis Key News
7.5 AbbVie
7.5.1 AbbVie Corporate Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.5.4 AbbVie Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.5.5 AbbVie Key News
7.6 Bristol-Myer
7.6.1 Bristol-Myer Corporate Summary
7.6.2 Bristol-Myer Business Overview
7.6.3 Bristol-Myer Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.6.4 Bristol-Myer Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Bristol-Myer Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.7.4 Sanofi Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Sanofi Key News
7.8 AstraZeneca
7.8.1 AstraZeneca Corporate Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.8.4 AstraZeneca Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.8.5 AstraZeneca Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.9.4 Merck Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Merck Key News
7.10 Amgen
7.10.1 Amgen Corporate Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.10.4 Amgen Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Amgen Key News
7.11 Bayer AG
7.11.1 Bayer AG Corporate Summary
7.11.2 Bayer AG Prostate Cancer Chemotherapy Drugs Business Overview
7.11.3 Bayer AG Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.11.4 Bayer AG Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Bayer AG Key News
7.12 Ipsen Group
7.12.1 Ipsen Group Corporate Summary
7.12.2 Ipsen Group Prostate Cancer Chemotherapy Drugs Business Overview
7.12.3 Ipsen Group Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.12.4 Ipsen Group Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Ipsen Group Key News
7.13 Endo Pharmaceuticals
7.13.1 Endo Pharmaceuticals Corporate Summary
7.13.2 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Business Overview
7.13.3 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.13.4 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Endo Pharmaceuticals Key News
7.14 Dendreon Corporation
7.14.1 Dendreon Corporation Corporate Summary
7.14.2 Dendreon Corporation Business Overview
7.14.3 Dendreon Corporation Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.14.4 Dendreon Corporation Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Dendreon Corporation Key News
7.15 Myovant Biosciences
7.15.1 Myovant Biosciences Corporate Summary
7.15.2 Myovant Biosciences Business Overview
7.15.3 Myovant Biosciences Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.15.4 Myovant Biosciences Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Myovant Biosciences Key News
7.16 Effector Therapeutics
7.16.1 Effector Therapeutics Corporate Summary
7.16.2 Effector Therapeutics Business Overview
7.16.3 Effector Therapeutics Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.16.4 Effector Therapeutics Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Effector Therapeutics Key News
7.17 Mediolanum
7.17.1 Mediolanum Corporate Summary
7.17.2 Mediolanum Business Overview
7.17.3 Mediolanum Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.17.4 Mediolanum Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.17.5 Mediolanum Key News
7.18 ESSA Pharma
7.18.1 ESSA Pharma Corporate Summary
7.18.2 ESSA Pharma Business Overview
7.18.3 ESSA Pharma Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.18.4 ESSA Pharma Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.18.5 ESSA Pharma Key News
7.19 Astellas Pharma
7.19.1 Astellas Pharma Corporate Summary
7.19.2 Astellas Pharma Business Overview
7.19.3 Astellas Pharma Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.19.4 Astellas Pharma Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.19.5 Astellas Pharma Key News
7.20 Janssen
7.20.1 Janssen Corporate Summary
7.20.2 Janssen Business Overview
7.20.3 Janssen Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.20.4 Janssen Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.20.5 Janssen Key News
7.21 Eli Lilly and Company
7.21.1 Eli Lilly and Company Corporate Summary
7.21.2 Eli Lilly and Company Business Overview
7.21.3 Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.21.4 Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.21.5 Eli Lilly and Company Key News
7.22 POINT Biopharma
7.22.1 POINT Biopharma Corporate Summary
7.22.2 POINT Biopharma Business Overview
7.22.3 POINT Biopharma Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.22.4 POINT Biopharma Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.22.5 POINT Biopharma Key News
7.23 Hinnova Pharmaceuticals
7.23.1 Hinnova Pharmaceuticals Corporate Summary
7.23.2 Hinnova Pharmaceuticals Business Overview
7.23.3 Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.23.4 Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.23.5 Hinnova Pharmaceuticals Key News
7.24 Sophiris Bio
7.24.1 Sophiris Bio Corporate Summary
7.24.2 Sophiris Bio Business Overview
7.24.3 Sophiris Bio Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.24.4 Sophiris Bio Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.24.5 Sophiris Bio Key News
7.25 Ultimovacs
7.25.1 Ultimovacs Corporate Summary
7.25.2 Ultimovacs Business Overview
7.25.3 Ultimovacs Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.25.4 Ultimovacs Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.25.5 Ultimovacs Key News
7.26 Foresee Pharmaceuticals
7.26.1 Foresee Pharmaceuticals Corporate Summary
7.26.2 Foresee Pharmaceuticals Business Overview
7.26.3 Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.26.4 Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.26.5 Foresee Pharmaceuticals Key News
7.27 Luye Pharma Group
7.27.1 Luye Pharma Group Corporate Summary
7.27.2 Luye Pharma Group Business Overview
7.27.3 Luye Pharma Group Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.27.4 Luye Pharma Group Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.27.5 Luye Pharma Group Key News
7.28 Abbott
7.28.1 Abbott Corporate Summary
7.28.2 Abbott Business Overview
7.28.3 Abbott Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.28.4 Abbott Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.28.5 Abbott Key News
7.29 Jiangsu HengRui Medicine
7.29.1 Jiangsu HengRui Medicine Corporate Summary
7.29.2 Jiangsu HengRui Medicine Business Overview
7.29.3 Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Major Product Offerings
7.29.4 Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Sales and Revenue in Global (2017-2022)
7.29.5 Jiangsu HengRui Medicine Key News
8 GLOBAL PROSTATE CANCER CHEMOTHERAPY DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Prostate Cancer Chemotherapy Drugs Production Capacity, 2017-2028
8.2 Prostate Cancer Chemotherapy Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Prostate Cancer Chemotherapy Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PROSTATE CANCER CHEMOTHERAPY DRUGS SUPPLY CHAIN ANALYSIS
10.1 Prostate Cancer Chemotherapy Drugs Industry Value Chain
10.2 Prostate Cancer Chemotherapy Drugs Upstream Market
10.3 Prostate Cancer Chemotherapy Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prostate Cancer Chemotherapy Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Prostate Cancer Chemotherapy Drugs in Global Market
Table 2. Top Prostate Cancer Chemotherapy Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Prostate Cancer Chemotherapy Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Prostate Cancer Chemotherapy Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Prostate Cancer Chemotherapy Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Prostate Cancer Chemotherapy Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Prostate Cancer Chemotherapy Drugs Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Prostate Cancer Chemotherapy Drugs Product Type
Table 9. List of Global Tier 1 Prostate Cancer Chemotherapy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Chemotherapy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2023-2028
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Prostate Cancer Chemotherapy Drugs Product Offerings
Table 48. Johnson & Johnson Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Prostate Cancer Chemotherapy Drugs Product Offerings
Table 51. Pfizer Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche Prostate Cancer Chemotherapy Drugs Product Offerings
Table 54. Roche Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Novartis Corporate Summary
Table 56. Novartis Prostate Cancer Chemotherapy Drugs Product Offerings
Table 57. Novartis Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. AbbVie Corporate Summary
Table 59. AbbVie Prostate Cancer Chemotherapy Drugs Product Offerings
Table 60. AbbVie Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Bristol-Myer Corporate Summary
Table 62. Bristol-Myer Prostate Cancer Chemotherapy Drugs Product Offerings
Table 63. Bristol-Myer Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Sanofi Corporate Summary
Table 65. Sanofi Prostate Cancer Chemotherapy Drugs Product Offerings
Table 66. Sanofi Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. AstraZeneca Corporate Summary
Table 68. AstraZeneca Prostate Cancer Chemotherapy Drugs Product Offerings
Table 69. AstraZeneca Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Merck Corporate Summary
Table 71. Merck Prostate Cancer Chemotherapy Drugs Product Offerings
Table 72. Merck Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Amgen Corporate Summary
Table 74. Amgen Prostate Cancer Chemotherapy Drugs Product Offerings
Table 75. Amgen Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Bayer AG Corporate Summary
Table 77. Bayer AG Prostate Cancer Chemotherapy Drugs Product Offerings
Table 78. Bayer AG Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Ipsen Group Corporate Summary
Table 80. Ipsen Group Prostate Cancer Chemotherapy Drugs Product Offerings
Table 81. Ipsen Group Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Endo Pharmaceuticals Corporate Summary
Table 83. Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Offerings
Table 84. Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Dendreon Corporation Corporate Summary
Table 86. Dendreon Corporation Prostate Cancer Chemotherapy Drugs Product Offerings
Table 87. Dendreon Corporation Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Myovant Biosciences Corporate Summary
Table 89. Myovant Biosciences Prostate Cancer Chemotherapy Drugs Product Offerings
Table 90. Myovant Biosciences Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Effector Therapeutics Corporate Summary
Table 92. Effector Therapeutics Prostate Cancer Chemotherapy Drugs Product Offerings
Table 93. Effector Therapeutics Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Mediolanum Corporate Summary
Table 95. Mediolanum Prostate Cancer Chemotherapy Drugs Product Offerings
Table 96. Mediolanum Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. ESSA Pharma Corporate Summary
Table 98. ESSA Pharma Prostate Cancer Chemotherapy Drugs Product Offerings
Table 99. ESSA Pharma Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Astellas Pharma Corporate Summary
Table 101. Astellas Pharma Prostate Cancer Chemotherapy Drugs Product Offerings
Table 102. Astellas Pharma Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Janssen Corporate Summary
Table 104. Janssen Prostate Cancer Chemotherapy Drugs Product Offerings
Table 105. Janssen Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Eli Lilly and Company Corporate Summary
Table 107. Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Product Offerings
Table 108. Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. POINT Biopharma Corporate Summary
Table 110. POINT Biopharma Prostate Cancer Chemotherapy Drugs Product Offerings
Table 111. POINT Biopharma Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 112. Hinnova Pharmaceuticals Corporate Summary
Table 113. Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Offerings
Table 114. Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 115. Sophiris Bio Corporate Summary
Table 116. Sophiris Bio Prostate Cancer Chemotherapy Drugs Product Offerings
Table 117. Sophiris Bio Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 118. Ultimovacs Corporate Summary
Table 119. Ultimovacs Prostate Cancer Chemotherapy Drugs Product Offerings
Table 120. Ultimovacs Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 121. Foresee Pharmaceuticals Corporate Summary
Table 122. Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Offerings
Table 123. Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 124. Luye Pharma Group Corporate Summary
Table 125. Luye Pharma Group Prostate Cancer Chemotherapy Drugs Product Offerings
Table 126. Luye Pharma Group Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 127. Abbott Corporate Summary
Table 128. Abbott Prostate Cancer Chemotherapy Drugs Product Offerings
Table 129. Abbott Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 130. Jiangsu HengRui Medicine Corporate Summary
Table 131. Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Product Offerings
Table 132. Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 133. Prostate Cancer Chemotherapy Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 134. Global Prostate Cancer Chemotherapy Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 135. Global Prostate Cancer Chemotherapy Drugs Production by Region, 2017-2022 (K Units)
Table 136. Global Prostate Cancer Chemotherapy Drugs Production by Region, 2023-2028 (K Units)
Table 137. Prostate Cancer Chemotherapy Drugs Market Opportunities & Trends in Global Market
Table 138. Prostate Cancer Chemotherapy Drugs Market Drivers in Global Market
Table 139. Prostate Cancer Chemotherapy Drugs Market Restraints in Global Market
Table 140. Prostate Cancer Chemotherapy Drugs Raw Materials
Table 141. Prostate Cancer Chemotherapy Drugs Raw Materials Suppliers in Global Market
Table 142. Typical Prostate Cancer Chemotherapy Drugs Downstream
Table 143. Prostate Cancer Chemotherapy Drugs Downstream Clients in Global Market
Table 144. Prostate Cancer Chemotherapy Drugs Distributors and Sales Agents in Global Market
Table 1. Key Players of Prostate Cancer Chemotherapy Drugs in Global Market
Table 2. Top Prostate Cancer Chemotherapy Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Prostate Cancer Chemotherapy Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Prostate Cancer Chemotherapy Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Prostate Cancer Chemotherapy Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Prostate Cancer Chemotherapy Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Prostate Cancer Chemotherapy Drugs Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Prostate Cancer Chemotherapy Drugs Product Type
Table 9. List of Global Tier 1 Prostate Cancer Chemotherapy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Chemotherapy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Prostate Cancer Chemotherapy Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Prostate Cancer Chemotherapy Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales, (K Units), 2023-2028
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Prostate Cancer Chemotherapy Drugs Product Offerings
Table 48. Johnson & Johnson Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Prostate Cancer Chemotherapy Drugs Product Offerings
Table 51. Pfizer Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche Prostate Cancer Chemotherapy Drugs Product Offerings
Table 54. Roche Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Novartis Corporate Summary
Table 56. Novartis Prostate Cancer Chemotherapy Drugs Product Offerings
Table 57. Novartis Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. AbbVie Corporate Summary
Table 59. AbbVie Prostate Cancer Chemotherapy Drugs Product Offerings
Table 60. AbbVie Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Bristol-Myer Corporate Summary
Table 62. Bristol-Myer Prostate Cancer Chemotherapy Drugs Product Offerings
Table 63. Bristol-Myer Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Sanofi Corporate Summary
Table 65. Sanofi Prostate Cancer Chemotherapy Drugs Product Offerings
Table 66. Sanofi Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. AstraZeneca Corporate Summary
Table 68. AstraZeneca Prostate Cancer Chemotherapy Drugs Product Offerings
Table 69. AstraZeneca Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Merck Corporate Summary
Table 71. Merck Prostate Cancer Chemotherapy Drugs Product Offerings
Table 72. Merck Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Amgen Corporate Summary
Table 74. Amgen Prostate Cancer Chemotherapy Drugs Product Offerings
Table 75. Amgen Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Bayer AG Corporate Summary
Table 77. Bayer AG Prostate Cancer Chemotherapy Drugs Product Offerings
Table 78. Bayer AG Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Ipsen Group Corporate Summary
Table 80. Ipsen Group Prostate Cancer Chemotherapy Drugs Product Offerings
Table 81. Ipsen Group Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Endo Pharmaceuticals Corporate Summary
Table 83. Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Offerings
Table 84. Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Dendreon Corporation Corporate Summary
Table 86. Dendreon Corporation Prostate Cancer Chemotherapy Drugs Product Offerings
Table 87. Dendreon Corporation Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Myovant Biosciences Corporate Summary
Table 89. Myovant Biosciences Prostate Cancer Chemotherapy Drugs Product Offerings
Table 90. Myovant Biosciences Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Effector Therapeutics Corporate Summary
Table 92. Effector Therapeutics Prostate Cancer Chemotherapy Drugs Product Offerings
Table 93. Effector Therapeutics Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Mediolanum Corporate Summary
Table 95. Mediolanum Prostate Cancer Chemotherapy Drugs Product Offerings
Table 96. Mediolanum Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. ESSA Pharma Corporate Summary
Table 98. ESSA Pharma Prostate Cancer Chemotherapy Drugs Product Offerings
Table 99. ESSA Pharma Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Astellas Pharma Corporate Summary
Table 101. Astellas Pharma Prostate Cancer Chemotherapy Drugs Product Offerings
Table 102. Astellas Pharma Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Janssen Corporate Summary
Table 104. Janssen Prostate Cancer Chemotherapy Drugs Product Offerings
Table 105. Janssen Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Eli Lilly and Company Corporate Summary
Table 107. Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Product Offerings
Table 108. Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. POINT Biopharma Corporate Summary
Table 110. POINT Biopharma Prostate Cancer Chemotherapy Drugs Product Offerings
Table 111. POINT Biopharma Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 112. Hinnova Pharmaceuticals Corporate Summary
Table 113. Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Offerings
Table 114. Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 115. Sophiris Bio Corporate Summary
Table 116. Sophiris Bio Prostate Cancer Chemotherapy Drugs Product Offerings
Table 117. Sophiris Bio Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 118. Ultimovacs Corporate Summary
Table 119. Ultimovacs Prostate Cancer Chemotherapy Drugs Product Offerings
Table 120. Ultimovacs Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 121. Foresee Pharmaceuticals Corporate Summary
Table 122. Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Offerings
Table 123. Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 124. Luye Pharma Group Corporate Summary
Table 125. Luye Pharma Group Prostate Cancer Chemotherapy Drugs Product Offerings
Table 126. Luye Pharma Group Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 127. Abbott Corporate Summary
Table 128. Abbott Prostate Cancer Chemotherapy Drugs Product Offerings
Table 129. Abbott Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 130. Jiangsu HengRui Medicine Corporate Summary
Table 131. Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Product Offerings
Table 132. Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 133. Prostate Cancer Chemotherapy Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 134. Global Prostate Cancer Chemotherapy Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 135. Global Prostate Cancer Chemotherapy Drugs Production by Region, 2017-2022 (K Units)
Table 136. Global Prostate Cancer Chemotherapy Drugs Production by Region, 2023-2028 (K Units)
Table 137. Prostate Cancer Chemotherapy Drugs Market Opportunities & Trends in Global Market
Table 138. Prostate Cancer Chemotherapy Drugs Market Drivers in Global Market
Table 139. Prostate Cancer Chemotherapy Drugs Market Restraints in Global Market
Table 140. Prostate Cancer Chemotherapy Drugs Raw Materials
Table 141. Prostate Cancer Chemotherapy Drugs Raw Materials Suppliers in Global Market
Table 142. Typical Prostate Cancer Chemotherapy Drugs Downstream
Table 143. Prostate Cancer Chemotherapy Drugs Downstream Clients in Global Market
Table 144. Prostate Cancer Chemotherapy Drugs Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Prostate Cancer Chemotherapy Drugs Segment by Type
Figure 2. Prostate Cancer Chemotherapy Drugs Segment by Application
Figure 3. Global Prostate Cancer Chemotherapy Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Chemotherapy Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Prostate Cancer Chemotherapy Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prostate Cancer Chemotherapy Drugs Revenue in 2021
Figure 9. By Type - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Prostate Cancer Chemotherapy Drugs Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Prostate Cancer Chemotherapy Drugs Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 19. US Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 24. Germany Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 33. China Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Prostate Cancer Chemotherapy Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Prostate Cancer Chemotherapy Drugs by Region, 2021 VS 2028
Figure 50. Prostate Cancer Chemotherapy Drugs Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Prostate Cancer Chemotherapy Drugs Segment by Type
Figure 2. Prostate Cancer Chemotherapy Drugs Segment by Application
Figure 3. Global Prostate Cancer Chemotherapy Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Chemotherapy Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Cancer Chemotherapy Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Prostate Cancer Chemotherapy Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prostate Cancer Chemotherapy Drugs Revenue in 2021
Figure 9. By Type - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Prostate Cancer Chemotherapy Drugs Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Prostate Cancer Chemotherapy Drugs Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 19. US Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 24. Germany Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 33. China Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Prostate Cancer Chemotherapy Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Prostate Cancer Chemotherapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Prostate Cancer Chemotherapy Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Prostate Cancer Chemotherapy Drugs by Region, 2021 VS 2028
Figure 50. Prostate Cancer Chemotherapy Drugs Industry Value Chain
Figure 51. Marketing Channels
